INDO US BIOTECH
|
INDO US BIOTECH Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹62 Cr | ₹50 Cr | ₹40 Cr | ₹40 Cr | ₹35 Cr |
Sales | ₹62 Cr | ₹50 Cr | ₹40 Cr | ₹40 Cr | ₹35 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹62 Cr | ₹50 Cr | ₹40 Cr | ₹40 Cr | ₹35 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-3.12 Cr | ₹-11 Cr | ₹-2.32 Cr | ₹1.64 Cr | ₹-4.51 Cr |
Raw Material Consumed | ₹5.27 Cr | ₹2.18 Cr | ₹2.46 Cr | ₹2.81 Cr | ₹27 Cr |
Opening Raw Materials | - | - | - | - | - |
Purchases Raw Materials | - | - | - | - | - |
Closing Raw Materials | - | - | - | - | - |
Other Direct Purchases / Brought in cost | ₹5.27 Cr | ₹2.18 Cr | ₹2.46 Cr | ₹2.81 Cr | ₹27 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹0.14 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.03 Cr | ₹0.03 Cr |
Electricity & Power | ₹0.14 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.03 Cr | ₹0.03 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1.19 Cr | ₹0.48 Cr | ₹0.34 Cr | ₹0.35 Cr | ₹0.27 Cr |
Salaries, Wages & Bonus | ₹1.12 Cr | ₹0.46 Cr | ₹0.28 Cr | ₹0.32 Cr | ₹0.23 Cr |
Contributions to EPF & Pension Funds | ₹0.03 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.02 Cr | - |
Workmen and Staff Welfare Expenses | ₹0.04 Cr | ₹0.01 Cr | ₹0.05 Cr | ₹0.00 Cr | ₹0.00 Cr |
Other Employees Cost | ₹0.01 Cr | ₹0.01 Cr | - | ₹0.02 Cr | ₹0.04 Cr |
Other Manufacturing Expenses | ₹45 Cr | ₹48 Cr | ₹29 Cr | ₹29 Cr | ₹7.20 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹0.02 Cr | ₹0.02 Cr | ₹0.24 Cr | ₹3.18 Cr | ₹0.83 Cr |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | ₹0.18 Cr | ₹0.31 Cr | ₹0.58 Cr | ₹0.11 Cr | - |
Other Mfg Exp | ₹45 Cr | ₹48 Cr | ₹28 Cr | ₹26 Cr | ₹6.37 Cr |
General and Administration Expenses | ₹1.57 Cr | ₹1.10 Cr | ₹1.35 Cr | ₹1.53 Cr | ₹1.87 Cr |
Rent , Rates & Taxes | ₹0.04 Cr | ₹0.08 Cr | ₹0.01 Cr | ₹0.00 Cr | - |
Insurance | ₹0.08 Cr | ₹0.05 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.01 Cr |
Printing and stationery | ₹0.03 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.12 Cr | ₹0.04 Cr |
Professional and legal fees | ₹0.60 Cr | ₹0.30 Cr | ₹0.35 Cr | ₹0.24 Cr | ₹0.10 Cr |
Traveling and conveyance | ₹0.31 Cr | ₹0.22 Cr | ₹0.12 Cr | ₹0.12 Cr | ₹0.13 Cr |
Other Administration | ₹0.52 Cr | ₹0.43 Cr | ₹0.82 Cr | ₹1.01 Cr | ₹1.59 Cr |
Selling and Distribution Expenses | ₹1.32 Cr | ₹1.53 Cr | ₹2.81 Cr | ₹0.55 Cr | ₹0.34 Cr |
Advertisement & Sales Promotion | ₹0.01 Cr | ₹0.02 Cr | ₹0.12 Cr | ₹0.34 Cr | - |
Sales Commissions & Incentives | ₹0.27 Cr | ₹0.59 Cr | ₹0.40 Cr | ₹0.12 Cr | - |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | ₹0.03 Cr | ₹0.03 Cr | ₹0.18 Cr | ₹0.10 Cr | - |
Other Selling Expenses | ₹1.02 Cr | ₹0.89 Cr | ₹2.11 Cr | - | ₹0.34 Cr |
Miscellaneous Expenses | ₹0.55 Cr | ₹1.06 Cr | ₹1.27 Cr | ₹0.02 Cr | ₹0.17 Cr |
Bad debts /advances written off | ₹0.55 Cr | ₹0.88 Cr | ₹1.25 Cr | - | - |
Provision for doubtful debts | - | ₹0.17 Cr | - | - | - |
Losson disposal of fixed assets(net) | - | - | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Losson foreign exchange fluctuations | - | - | - | - | ₹0.14 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | - | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹52 Cr | ₹43 Cr | ₹35 Cr | ₹36 Cr | ₹32 Cr |
Operating Profit (Excl OI) | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr | ₹3.96 Cr | ₹3.42 Cr |
Other Income | ₹0.02 Cr | ₹0.18 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.03 Cr |
Interest Received | - | ₹0.00 Cr | ₹0.00 Cr | - | ₹0.00 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹0.02 Cr | ₹0.08 Cr | ₹0.03 Cr | - | - |
Foreign Exchange Gains | - | - | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr |
Others | ₹0.00 Cr | ₹0.10 Cr | ₹0.00 Cr | ₹0.01 Cr | ₹0.02 Cr |
Operating Profit | ₹9.41 Cr | ₹7.11 Cr | ₹5.56 Cr | ₹3.97 Cr | ₹3.45 Cr |
Interest | ₹1.20 Cr | ₹1.20 Cr | ₹1.18 Cr | ₹0.88 Cr | ₹0.40 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹1.12 Cr | ₹1.14 Cr | ₹1.12 Cr | ₹0.78 Cr | ₹0.34 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.08 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.10 Cr | ₹0.06 Cr |
Other Interest | ₹0.00 Cr | ₹0.00 Cr | - | ₹0.01 Cr | - |
PBDT | ₹8.21 Cr | ₹5.91 Cr | ₹4.38 Cr | ₹3.09 Cr | ₹3.05 Cr |
Depreciation | ₹0.83 Cr | ₹0.42 Cr | ₹0.25 Cr | ₹0.21 Cr | ₹0.24 Cr |
Profit Before Taxation & Exceptional Items | ₹7.39 Cr | ₹5.49 Cr | ₹4.13 Cr | ₹2.87 Cr | ₹2.81 Cr |
Exceptional Income / Expenses | - | - | - | ₹-0.01 Cr | - |
Profit Before Tax | ₹7.39 Cr | ₹5.49 Cr | ₹4.13 Cr | ₹2.86 Cr | ₹2.81 Cr |
Provision for Tax | ₹0.15 Cr | ₹0.25 Cr | ₹-0.97 Cr | ₹0.33 Cr | ₹0.72 Cr |
Current Income Tax | ₹0.34 Cr | ₹0.38 Cr | - | ₹0.22 Cr | ₹0.43 Cr |
Deferred Tax | ₹-0.17 Cr | ₹-0.16 Cr | ₹-0.33 Cr | ₹0.08 Cr | ₹0.29 Cr |
Other taxes | ₹-0.02 Cr | ₹0.03 Cr | ₹-0.64 Cr | ₹0.03 Cr | ₹0.00 Cr |
Profit After Tax | ₹7.24 Cr | ₹5.24 Cr | ₹5.10 Cr | ₹2.54 Cr | ₹2.09 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹15 Cr | ₹11 Cr | ₹6.14 Cr | ₹3.61 Cr | ₹1.52 Cr |
Appropriations | ₹22 Cr | ₹16 Cr | ₹11 Cr | ₹6.14 Cr | ₹3.61 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | ₹1.37 Cr | - | - | - |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹7.22 | ₹5.71 | ₹8.40 | ₹4.18 | ₹4.30 |
Adjusted EPS | ₹3.61 | ₹2.86 | ₹3.50 | ₹1.74 | ₹1.43 |
Compare Income Statement of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹455.2 Cr | -0.7% | -11.5% | -7.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹14,765.8 Cr | -0.4% | 3.4% | 25% | Stock Analytics | |
KAVERI SEED COMPANY | ₹4,941.2 Cr | 2.2% | 6.2% | 41.3% | Stock Analytics | |
VENKYS (INDIA) | ₹2,505.2 Cr | 5.6% | 8% | -8.4% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,669.8 Cr | -2.7% | 9.4% | -30% | Stock Analytics | |
TIERRA AGROTECH | ₹345.7 Cr | -0.6% | -7.3% | -39.8% | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -0.7% |
-11.5% |
-7.7% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses